Authors:
Borel, C
Schorr, O
Durand, I
Zoulim, F
Kay, A
Trepo, C
Hantz, O
Citation: C. Borel et al., Initial amplification of duck hepatitis B virus covalently closed circularDNA after in vitro infection of embryonic duck hepatocytes is increased bycell cycle progression, HEPATOLOGY, 34(1), 2001, pp. 168-179
Authors:
Le Guerhier, F
Pichoud, C
Jamard, C
Guerret, S
Chevallier, M
Peyrol, S
Hantz, O
King, I
Trepo, C
Cheng, YC
Zoulim, F
Citation: F. Le Guerhier et al., Antiviral activity of beta-L-2 ',3 '-dideoxy-2 ',3 '-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus, ANTIM AG CH, 45(4), 2001, pp. 1065-1077
Authors:
Le Guerhier, F
Pichoud, C
Guerret, S
Chevallier, M
Jamard, C
Hantz, O
Li, XY
Chen, SH
King, I
Trepo, C
Cheng, YC
Zoulim, F
Citation: F. Le Guerhier et al., Characterization of the antiviral effect of 2 ',3 '-dideoxy-2 ', 3 '-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model, ANTIM AG CH, 44(1), 2000, pp. 111-122
Authors:
Seigneres, B
Pichoud, C
Ahmed, SS
Hantz, O
Trepo, C
Zoulim, F
Citation: B. Seigneres et al., Evolution of hepatitis B virus polymerase gene sequence during famciclovirtherapy for chronic hepatitis B, J INFEC DIS, 181(4), 2000, pp. 1221-1233
Authors:
Hantz, O
Perigaud, C
Borel, C
Jamard, C
Zoulim, F
Trepo, C
Imbach, JL
Gosselin, G
Citation: O. Hantz et al., The SATE pronucleotide approach applied to acyclovir - Part II. Effects ofbis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo, ANTIVIR RES, 40(3), 1999, pp. 179-187